πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 63 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8927730

Intramolecular hydrogen-bonded nitric oxide synthase inhibitors

Northwestern University Β· Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883438

Method for diagnosing cell proliferation disorders having a neoactive mutation at residue

Agios Pharmaceuticals, Inc. Β· Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8802733

Aldehyde dehydrogenase inhibitors as novel depigmenting agents

The Board of Regents of the University of Texas System Β· Granted Tue Aug 12 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 07 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8481599

Compositions and methods for increasing compliance with therapies using aldehyde dehydroge

TONIX PHARMACEUTICALS HOLDING CORP Β· Granted Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8114900

Amorphous carvedilol dihydrogen phosphate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8092838

Use of hydrogen sulfide in the treatment of eye diseases

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7998992

Oxazolidinone derivative having inhibitory activity on 11Ξ²-hydroxysteroid dehydrogenase ty

Institute of Medicinal Molecular Design, Inc. Β· Granted Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7759339

Hydroxysteroid dehydrogenase inhibitors

Takeda San Diego, Inc. Β· Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7527952

Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7276629

Hydrogenation of imine intermediates of sertraline with catalysts

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6375946

Enhanced activation of natural killer cells using an NK cell activator and a hydrogen pero

Maxim Pharmaceuticals, Inc. Β· Granted Tue Apr 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6328959

Intestinal hydrogen removal using hydrogen-metabolizing microbes

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Dec 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245563

Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxi

Maxim Pharmaceuticals, Inc. Β· Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071509

Enhanced activation of natural killer cells using an NK cell activator and a hydrogen pero

Maxim Pharmaceuticals, Inc. Β· Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6063373

Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scaveng

Maxim Pharmaceuticals, Inc. Β· Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired